It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine ...
The pharmaceutical company said, “The allegations that came out in the media are entirely baseless, distorted, and part of a smear campaign" ...
Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine technology ...
National Institutes of Health officials have urged scientists to remove all references to mRNA vaccine technology from their ...
Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine ...
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.
Pfizer and BioNTech, which collaborated on the mRNA vaccine, argued that Moderna—in a press statement from October ...
Norovirus is also hard to kill on surfaces, where it can live for days to weeks. If someone in your household vomits in the ...
In late February, Elanco Animal Health Inc. (ELAN) announced a new agreement with South Dakota-based Medgene to leverage the company's innovative vaccine platform technology. The agreement includes ...
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In ...
Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic insider stock purchases ...
Moderna’s Bird Flu Vaccine Faces Uncertainty Moderna is facing potential financial difficulties, as the Trump administration is considering canceling a $590 million contract for the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results